BioUtah Announces Early Bird Registration for 2025 Utah Life Sciences Summit with High-Profile Speakers

BioUtah, Utah's trade association for the life sciences community, has opened Early Bird registration for the 2025 Utah Life Sciences Summit presented by Mayer Brown. The event will be held November 12 at the Hilton, Salt Lake City Center, with reduced pricing available through October 17. Registration is available at https://bioutah.org/summit-registration while the preliminary agenda can be viewed at https://bioutah.org/summit-agenda.

The summit typically attracts over 500 registrants, convening top life sciences leaders, experts, policymakers, and professionals to discuss important industry dynamics, regulatory landscapes, market trends, and strategies to promote innovation and advance healthcare. Kelvyn Cullimore, president and CEO of BioUtah, emphasized that the flagship event brings together the best and brightest in the sector for a day of discovery, collaboration, and inspiration, spanning from groundbreaking startups to established industry leaders.

Utah has emerged as one of the nation's fastest-growing life sciences hubs, contributing $22.6 billion to Utah's GDP and supporting approximately 180,000 jobs. The economic and social impact extends throughout the state and beyond, making this summit particularly significant for understanding the sector's trajectory and opportunities.

The speaker lineup includes several high-profile figures who will cover thought-provoking topics impacting all segments of Utah's life sciences ecosystem. Melissa Holyoak, Commissioner of the Federal Trade Commission, brings expertise in consumer protection, constitutional law, healthcare market competition, and mergers and acquisitions. Michelle Tarver, MD, PhD, Director of FDA's Center for Devices and Radiological Health, will hold a virtual FDA Town Hall discussion about the agency's policy priorities and regulatory initiatives.

Peter Marks, MD, a hematologist and oncologist who previously headed the FDA's Center for Biologics Evaluation and Research, will share insights from overseeing rapid expansion in FDA-approved cell and gene therapies and his key role in establishing Operation Warp Speed that accelerated COVID-19 vaccine development. Carter Dredge, Executive Director of the Intermountain Health Institute, rounds out the keynote speakers as a global healthcare thought leader who partners with top thinkers to create novel solutions to complex problems.

The summit will feature dedicated networking opportunities, including a lunchtime program designed to facilitate meaningful professional connections and conversations with colleagues. Attendees can choose from multiple subject-specific tracks covering workforce development, market access, regulatory and quality standards, and legal considerations. BioUtah will also present awards throughout the day to individuals and companies for their valuable contributions and achievements in the life sciences field.

According to Cullimore, the summit offers relevant and engaging content whether participants focus on medical device manufacturing, diagnostics, or biopharmaceuticals. The combination of regulatory insights from federal officials, innovation perspectives from industry leaders, and networking opportunities creates a comprehensive platform for advancing healthcare solutions and business strategies within Utah's rapidly expanding life sciences ecosystem.